| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.047 | 0.4 |